Radiopharmaceuticals Market Size, Scope, and Share by 2031
Radiopharmaceuticals Market: Strategic Insights
Radiopharmaceuticals Market
-
CAGR (2023 - 2031)14.4% -
Market Size 2023
US$ 9.07 Billion -
Market Size 2031
US$ 26.51 Billion
Market Dynamics
GROWTH DRIVERS
- Rising Prevalence of Chronic Diseases
- Growing Number of Clinical Trials in Targeted Therapy
FUTURE TRENDS
- Short Shelf-Life of Radiopharmaceuticals
OPPORTUNITIES
- High Growth Potential in Developing Countries
Key Players
- Medi Radiopharma MRP
- Rotem Industries Ltd
- ABX Advanced Biochemical Compounds GmbH
- Invicro LLC
- Cardinal Health
- Newcastle University
- Novartis
- Curium
- Blue Earth Diagnostics
- General Electric Company
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Application
- Oncology
- Cardiology
- Neurology
- Pulmonary
- Urology
Type
- Diagnostic
- Therapeutic
Tracer Type
- Tc-99m
- F-18
- Ga-68
- TL-201
- I-131
- Fe-59
- Lu-171
- RB-82 and N-13
- Cr-51 and P-32
- Sc-46
- Sg-269 and Hs-269
End User
- Hospitals and Clinics
- Diagnostic Centers
- Academic and Research Institutes